- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05937100
New Vital Pulpotomy Medications in Primary Molars
July 7, 2023 updated by: Weaam ibrahiem eltantawy, Mansoura University
Clinical and Radiographic Evaluation of Hyaluronic Acid and Biodentine as Vital Pulpotomy Medications in Primary Molars: Randomized Controlled Clinical Trial
Evaluate clinically and radiographically the effect of biodentine and hyaluronic acid (HA) versus formocresol (FC) as pulpotomy medications in primary molars.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Detailed Description
Split mouth randomized controlled clinical trial. This study will be conducted on 96 teeth from 48 children in age group 4-7 years and have bilateral lower primary molars indicated for vital pulpotomy procedure. for:
- Clinical evaluation of biodentine, hyaluronic acid and formocresol groups according to presence of failure criteria at different follow up periods.
- Radiographic evaluation of biodentine, hyaluronic acid and formocresol groups according to presence of failure criteria at different follow up periods.
Study Type
Interventional
Enrollment (Estimated)
48
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Mansoura, Egypt, 35511
- Dentistry
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
-Clinical criteria
- Restorable mandibular primary molars with deep carious lesions.
- Absence of gingival swelling or sinus tract.
- Absence of spontaneous pain
- Absence of pain on percussion. B-Radiographic Criteria: Absence of
- Discontinuity of lamina dura
- Internal root resorption.
- External root resorption.
- inter-radicular or periapical bone destruction (radiolucency)
Exclusion Criteria:
- Excessive bleeding during pulp amputation.
- Non vital/necrotic teeth.
- Any sort of medical history contraindicating the pulp treatment.
- Teeth approximate exfoliation
- Patient's guardians are not intending to be part of the study.
- Retreatment of previously pulpotomy treated molar -
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: control: Formocresol
Teeth will be treated by using squeezed sterile cotton pellet with 20% formcresol for 1 minute then removed and pulp stumps will be dressed with a layer of zinc oxide-eugenol (ZOE) paste.
|
Molars will be anesthetized by local anesthesia.
The rubber dam will be used for isolation.
Caries will be removed by large spoon excavator.
When pulpal exposure occurs, deroofing of the pulp chamber will be achieved then pulpal tissue will be amputated using sharp excavator.
Hemostasis will be obtained by applying pressure with saline moist cotton pellet.
If bleeding has not stopped within 5 min, tooth will be excluded from the study.Teeth will be treated by using squeezed sterile cotton pellet with 20% formcresol for 1 minute
|
Experimental: Group A : (Biodentine)
The biodentine mix will be prepared according to the manufacturer's instructions and condensed lightly with a condenser on the pulp stumps, and allowed to set.
|
Molars will be anesthetized by local anesthesia.
The rubber dam will be used for isolation.
Caries will be removed by large spoon excavator.
When pulpal exposure occurs, deroofing of the pulp chamber will be achieved then pulpal tissue will be amputated using sharp excavator.
Hemostasis will be obtained by applying pressure with saline moist cotton pellet.
If bleeding has not stopped within 5 min, tooth will be excluded from the study.The biodentine mix will be prepared according to the manufacturer's instructions and condensed lightly with a condenser on the pulp stumps
|
Experimental: Group B : (Hyaluronic acid gel)
Hyaluronic acid gel will be compressed against the amputated pulp for 5 minutes.
Then the pulp stumps will be dressed with a layer of zinc oxide-eugenol (ZOE) paste.
|
Molars will be anesthetized by local anesthesia.
The rubber dam will be used for isolation.
Caries will be removed by large spoon excavator.
When pulpal exposure occurs, deroofing of the pulp chamber will be achieved then pulpal tissue will be amputated using sharp excavator.
Hemostasis will be obtained by applying pressure with saline moist cotton pellet.
If bleeding has not stopped within 5 min, tooth will be excluded from the study.Hyaluronic acid gel will be compressed against the amputated pulp for 5 minutes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
clinically successful pulpotomy
Time Frame: 18 months
|
|
18 months
|
radiographically successful pulpotomy
Time Frame: 18 months
|
|
18 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Weaam I El-tantawy, assistant lecturer ,Faculty of Dentistry, Mansoura University B.D.S (2016)
- Study Director: Nadia M Farrag, Professor ,Faculty of Dentistry, Mansoura University
- Study Director: Hossam E Hammouda, Lecturer, Faculty of Dentistry, Mansoura University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2023
Primary Completion (Estimated)
November 1, 2024
Study Completion (Estimated)
November 1, 2024
Study Registration Dates
First Submitted
June 30, 2023
First Submitted That Met QC Criteria
July 7, 2023
First Posted (Actual)
July 10, 2023
Study Record Updates
Last Update Posted (Actual)
July 10, 2023
Last Update Submitted That Met QC Criteria
July 7, 2023
Last Verified
June 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- A0103023PP
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Carious Exposure of Pulp
-
Gihan M Abuelniel ,PhDCairo UniversityCompletedCarious Exposure of Pulp
-
Cairo UniversityNot yet recruiting
-
King's College LondonGuy's and St Thomas' NHS Foundation TrustNot yet recruitingDeep Caries | Carious Exposure of Pulp
-
Jordan University of Science and TechnologyRecruitingIrreversible Pulpitis | Pulpotomy | Carious Exposure of PulpJordan
-
Cairo UniversityActive, not recruitingDeep Caries | Pulp Exposure, DentalEgypt
-
University of TromsoNorwegian Public dental health serviceCompletedReversible Pulpitis | Mature Teeth | Proximal Caries | Carious Exposure | Human Permanent First and Second Molars | Healthy PulpLithuania, Norway
-
Ahmad ElheenyRecruiting
-
Istanbul Medipol University HospitalEnrolling by invitationPulp Exposure, DentalTurkey
-
University of ValenciaUnknownIndirect Pulp Capping | Reversible Pulpitis | Deep Carious LesionsSpain
Clinical Trials on Formocresol
-
Ain Shams UniversityCompleted
-
Sarah Abdelbar MahmoudNot yet recruiting
-
Mashhad University of Medical SciencesUnknownTooth Diseases | Pulpitis | Dental Pulp DiseaseIran, Islamic Republic of
-
Texas A & M University Baylor College Of DentistryUnknownDental Caries Extending to Pulp
-
King Abdulaziz UniversityCompletedDental Caries | PulpotomySaudi Arabia
-
National Taiwan University HospitalUnknownDental Pulp DiseaseTaiwan
-
Universidade do Vale do SapucaiCompleted
-
Université de MontréalSt. Justine's Hospital; SeptodontCompletedDeep Dental CariesCanada